Literature DB >> 12479843

The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance, and maintenance versus manipulation-functions of working memory.

S C J Huijbregts1, L M J de Sonneville, F J van Spronsen, R Licht, J A Sergeant.   

Abstract

In this paper, we review neuropsychological test results of early and continuously treated Phenylketonuria (PKU) patients. To increase insight into the neuropsychological profile of this population, we have attempted to place the results within an attentional network model [Images of the mind, 1994], which proposes interacting but dissociable attentional networks for orienting, vigilance, and executive control of attention. Executive control of attention is discussed against the background of the process-specific theory of working memory (WM) [Handbook of neuropsychology, 1994], which postulates a distinction between the 'maintenance'-function of WM and the 'manipulation and monitoring'-function. Neuropsychological results are presented for 67 early and continuously treated PKU patients and 73 controls aged 7-14 years. Four neuropsychological tasks were employed to measure orienting, mnemonic processing, interference suppression, and top-down control in visual search. No differences were found in orienting and the maintenance-function of WM. In addition to previously reported impairments in sustained attention/vigilance and inhibition of prepotent responding, PKU patients exhibited deficits when top-down control was required in a visual search task, but showed no impairment when interference suppression was required. It is discussed how the specific neuropsychological impairments in PKU may be a consequence of mid-dorsolateral prefrontal cortex (DLPFC) dysfunctioning due to deficiencies in catecholamine modulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479843     DOI: 10.1016/s0149-7634(02)00040-4

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  20 in total

1.  Converging evidence does not support GIT1 as an ADHD risk gene.

Authors:  Marieke Klein; Monique van der Voet; Benjamin Harich; Kimm J E van Hulzen; A Marten H Onnink; Martine Hoogman; Tulio Guadalupe; Marcel Zwiers; Johanne M Groothuismink; Alicia Verberkt; Bonnie Nijhof; Anna Castells-Nobau; Stephen V Faraone; Jan K Buitelaar; Annette Schenck; Alejandro Arias-Vasquez; Barbara Franke
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-06-10       Impact factor: 3.568

2.  Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats.

Authors:  Priscila Nicolao Mazzola; Melaine Terra; Andrea Pereira Rosa; Caroline Paula Mescka; Tarsila Barros Moraes; Bruna Piccoli; Carlos Eduardo Jacques; Giovana Dalazen; Marcelo Xavier Cortes; Juliana Coelho; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2011-09-27       Impact factor: 3.584

3.  Effects of dietary management of phenylketonuria on long-term cognitive outcome.

Authors:  Shelley Channon; Galya Goodman; Sally Zlotowitz; Caroline Mockler; Philip J Lee
Journal:  Arch Dis Child       Date:  2006-10-26       Impact factor: 3.791

4.  Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents.

Authors:  Eva Thimm; Lisa Elena Schmidt; Katrin Heldt; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

5.  Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.

Authors:  Rachael Sharman; Karen A Sullivan; Ross McD Young; James J McGill
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

6.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

Review 7.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

8.  Dietary habits and metabolic control in adolescents and young adults with phenylketonuria: self-imposed protein restriction may be harmful.

Authors:  A M Das; K Goedecke; U Meyer; N Kanzelmeyer; S Koch; S Illsinger; T Lücke; H Hartmann; K Lange; H Lanfermann; L Hoy; X-Q Ding
Journal:  JIMD Rep       Date:  2013-11-13

Review 9.  Phenylketonuria: a review of current and future treatments.

Authors:  Naz Al Hafid; John Christodoulou
Journal:  Transl Pediatr       Date:  2015-10

Review 10.  Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?

Authors:  F J van Spronsen; Marieke Hoeksma; Dirk-Jan Reijngoud
Journal:  J Inherit Metab Dis       Date:  2009-01-13       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.